This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

RECTOGESIC-product-image

STEXEROL-D3

colecalciferol

Stexerol-D3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin D deficiency, or as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.1

Adverse Events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

Click here for prescribing information.

Stexerol-D3 is a simple solution for treatment and prevention of vitamin D deficiency and insufficiency in adult patients.1

Stexerol-D3 has a range of features to suit your patient’s needs.

High and low dose vitamin D3 tablets

Stexerol-D3 is available at both high 25,000 IU and low 1,000 IU doses, allowing for continuity of treatment with both loading and maintenance regimes.1 A flexible treatment regime can be tailored to a particular patient’s needs or to meet the dosing guideline requirements.2

Licensed treatment

Stexerol-D3 is a licensed vitamin D treatment. Licensing provides assurance of consistency, efficacy and quality. General Medical Council (GMC) guidance states there is an increased responsibility when prescribing unlicensed medications when licensed are available.3

Unlicensed products:

  • May have a variable content.
  • May not have medical information or pharmacovigilance support.
  • Are not produced to the same manufacturing standards required for licensed medicines.

Gelatin-free / suitable for vegetarians

Stexerol-D3 is gelatin-free, meaning it is suitable for patients who follow vegetarian diets.1

Halal certified / Kosher

Stexerol-D3 is certified halal4 and kosher5, meaning it is suitable for patients who follow these diets for religious or cultural reasons.

  • Halal – Muslim (Halal Authority Board).
  • Kosher – Jewish (Federation of Synagogues - Kashrus Board).

Nut-free and soya-free

Stexerol-D3 is nut-free and soya-free, meaning it is suitable for patients who suffer from nut or soya allergies.1

From a UK-based manufacturer1

UK service and support.1

Average:

  • References

    1. Stexerol-D3 Tablets SPC.

    2. Royal Osteoporosis Society: Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. Available at: https://strwebprdmedia.blob.core.windows. net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february-2020.pdf/ Last accessed: June 2024.

    3. General Medical Council: Good practice in prescribing and managing medicines and devices, 2013. Available at: https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/good-practice-in-prescribing-and-managing-medicines-and-devices/prescribing-unlicensed-medicines/ Last accessed: June 2024.

    4. Halal Authority Board. Vitamin D3 Film Coated Tablets Halal Certificate.

    5. Federation of Synagogues. Vitamin D3 Film Coated Tablets Kosher Certificate.

    M-SD3-UK-11-23-0003 June 2024